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Abstract
Mycetoma is a neglected tropical disease endemic in tropical and subtropical countries, par-
ticularly Sudan. The disease is characterised by the triad of painless subcutaneous mass,
multiple sinuses and discharge that contain grains. It is a chronic, debilitating disease most
commonly affecting the feet or hands and leads to substantial morbidity, loss of function and
even amputation. It predominantly affects poor, rural populations and patients typically pres-
ent late with advanced disease and complications. In this descriptive cross-sectional study,
we characterise the disabling consequences of mycetoma. The study included 300 patients;
228 (76%) male and 72 (24%) female with confirmed mycetoma seen at the Mycetoma
Research Centre, University of Khartoum, Sudan in the period May 2016 and January 2017.
The study design was based upon the International Classification of Functioning, Disability
and Health, examining the impact of mycetoma on eight life domains. Our major finding is
that mycetoma is a significantly disabling disease. Over 60% of the study population (181
patients) had moderate impairment or difficulty in at least one domain variable. The impor-
tant disability was mobility impairment and walking difficulty that was reported in 119
patients (39.7%). There was significant pain associated with mycetoma lesions in 103
patients (34%), challenging the traditional view of mycetoma as a painless disease. The
economic burden was also found to be substantial, with 126 patients (46.7%) reporting barri-
ers to their ability to sustain themselves. This is the first study evaluating the disabling con-
sequences of mycetoma and shows clear areas for intervention and further research.
Options for mitigating social and economic impacts include routine integration of analgesia
and physiotherapy into treatment protocols, and adapting educational provision and working
practices based on disability assessment. Our data show that mycetoma is a public health
issue with direct implications on quality of life.
Author summary
Mycetoma is a neglected tropical disease endemic in many tropical and subtropical coun-
tries affecting poor, rural populations. It commonly affects the feet or hands and leads to
substantial chronic morbidity, loss of function and disability. The disabling consequences
of mycetoma have not been studied before. In this study we interviewed 300 patients and
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asked them to what extent mycetoma has affected their lives across several functional
domains. We looked at bodily function, mobility, self-care, domestic activities, interper-
sonal interactions and relationships, education, economic status, and community, social
and civic life. We found that mycetoma causes significant disability and pain. It also
causes a significant financial burden to patients, interfering with their ability to be eco-
nomically self-sufficient and to gain remunerative employment. We also found that myce-
toma prevents the attainment of education. To overcome mycetoma-related disability we
recommend integrating analgesia and physiotherapy into clinical services, adapting edu-
cational provision and working practices and early case detection and treatment to avoid
the disease disabling consequences.
Introduction
Mycetoma is a neglected tropical disease frequently affecting the poorest of the poor in remote,
poor communities [1]. It is endemic in many tropical and subtropical countries around the
world including Sudan [2, 3]. The geographical distribution of mycetoma depends on a range
of environmental factors such as rainfall, humidity and temperature [4, 5]. Mycetoma has a
higher prevalence in rural areas with poor domestic hygiene [6, 7]. The disease is caused by
more than 50 microorganisms of fungal or bacterial origin, and hence it is classified as eumy-
cetoma and actinomycetoma respectively [8, 9]. Mycetoma is believed to occur as a result of
traumatic implantation of the causative organism into the subcutaneous tissue via minor
trauma or injury [10, 11]. It then spreads to involve the skin, deep tissues and bone leading to
massive destruction, deformities and disabilities [12, 13]. If untreated it can have a major
impact on the affected patients, communities and the health system in endemic countries
[14, 15].
The disease is characterised by the triad of subcutaneous mass, multiple sinuses and dis-
charge containing grains [16, 17]. It is most frequently seen in the foot and hand, which
account for 86% of reported cases, though no site is exempt [18, 19]. Mycetoma is most preva-
lent amongst children and young adults, with patients frequently presenting with advanced
disease. Delayed presentation may result from patients’ low socio-economic status and health
education levels, and the paucity of health services in distant, isolated endemic areas. Overall,
these factors lead to a devastating socio-economic impact [20, 21, 22, 23, 24]. Currently, the
available treatments (combination antimicrobial therapy for actinomycetoma, or antifungal
therapy for eumycetoma) have proved ineffective and expensive, with a range of side effects
and high recurrence rate [25, 26]. Late presentations often necessitate amputation or destruc-
tive surgical excisions [27, 28, 29]. Patients require long-term follow-up to monitor recovery
and recurrence, and unfortunately these factors as well as travel and opportunity cost of
attending clinic lead to a high loss to follow up.
The disabling consequences of mycetoma are poorly understood. A medical literature
search revealed no report addressing the present study objectives, and hence this study was
designed to determine the disabling impact of mycetoma upon patients. We aim to identify
key areas for future study with the ultimate goal of building evidence-based intervention and
appropriate health care for those affected.
The mycetoma-related disability burden is hypothesised to be significant for several rea-
sons. Firstly, the disease leads to structural impairment of the limbs, the most commonly
affected parts, and disability arises from the direct loss of function. Secondly, current treatment
options are limited and suboptimal, with disease potentially lasting for decades, resulting in
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increasing impairments over time. Finally, support and adaptation for individuals with any
disabling consequences of mycetoma are limited in Sudan, as indeed they are for many other
disabling neglected conditions around the world.
As far as the authors know, this is the first-ever study of the disabling consequences of
mycetoma.
Material & methods
Study design
The study was designed using the International Classification of Functioning, Disability and
Health (ICF). The ICF is a standardized framework and classification for the description of
health and health related states [30]. It conceptualises disability as an interaction between the
patient health condition and his/her environment. Functions relate to body functioning (emo-
tional state, pain, physical movement etc.), activities (driving, walking, etc.), and participation
in society (engaging with religious ceremonies, etc.). Disability in this framework is a term for
impairments or restrictions in functioning [31].
Study design, questions and qualifiers were taken directly from the ICF. Questions were
selected based on their relevance to mycetoma and were purposefully broad, encompassing a
range of possible impacts. All the possible questions in the ICF were reviewed; six questions
from Body Functioning and 27 from Activities and Participation, thus 33 variables were
selected. Answers to the questions were not ‘yes’ or ‘no’. Rather, grades of severity of the
impairment or difficulty with a scale of mild, moderate, severe, or complete were used to fur-
ther delineate the impact of the disease on individuals. These qualifiers for each grade were
taken from the ICF (Table 1).
Data collection
The data was collected by four recently graduated doctors. Prior to the data collection, they
had a four-day training course on data collection and interview skills provided by the first
author. The training also included role-play, real-life interview assessment and an examination
at the end of the course, following which their first two patients’ interviews were additionally
observed for performance quality. They each passed the different parts of the training course.
The interviews were conducted each Monday at the Mycetoma Clinic of the Mycetoma
Research Centre (MRC), University of Khartoum, between May 2016 and January 2017. To
prevent selection bias, patients with confirmed mycetoma were given a number on arrival.
Table 1. Description of qualifiers.
Qualifier Description Score
Given
No impairment or
difficulty
A person has no problem 0
Mild impairment or
difficulty
A problem that is present less than 25% of the time, with an intensity which
a person can tolerate and which happens occasionally over the last 30 days
1
Moderate impairment or
difficulty
A problem that is present less than 50% of the time, with an intensity which
is interfering in a person’s day to day life and which happens occasionally
over the last 30 days
2
Severe impairment or
difficulty
A problem that is present more than 50% of the time, with an intensity
which is partially disrupting the person’s day to day life and which happens
frequently over the last 30 days
3
Complete impairment or
difficulty
A problem that is present more than 95% of the time, with an intensity
which is totally disrupting to the person’s day to day life and which happens
every day over the last 30 days
4
https://doi.org/10.1371/journal.pntd.0007019.t001
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Every third patient was chosen to be part of the study. Patients attended the clinic for their reg-
ular appointment and were interviewed either before or after their review. Patients who
attended clinic Tuesday-Friday were not interviewed. We were able to survey 300 patients
within the defined time scale of the project. Patients were given the option to decline and the
interview was conducted in privacy. Ethical clearance was obtained from the Mycetoma
Research Centre IRB and every patient gave verbal informed consent.
Data analysis
A scoring system for the various mycetoma-related disability variables studied was created.
The variables included impairment in bodily functions or difficulty in activities and participa-
tion in society. A mild impairment or difficulty was given a value of one; that of moderate was
given a value of two; severe was given a value of three, and complete inability to perform a
given task or participate in activity was given a value of four. These values were added up over
the 33 variables into a cumulative disability score that was used during data analysis. The statis-
tical software used was Statistical Package for the Social Sciences and a P value of<0.05
denoted statistical significance. Correlations were determined using a Pearson co-efficient
bivariate two-tailed test.
Results
Demographic
Between May 2016 and January 2017, 300 patients were interviewed; of these 228 (76%) were
males and 72 (24%) were females with a gender ratio of 3:1. The mean age of the studied par-
ticipants was 32.1 years with a sample standard deviation of 14.0 years; the youngest was 5
years old and the oldest was 74 years old; 39% of them were between the ages of 5–25 years,
49% between 26–50 years, and 12% were aged 51 to 74 years. The participants were most com-
monly students (16%), farmers (13%), and housewives (11.3%). In 36% of participants, the
occupation was unspecified.
The mycetoma mean duration was 7.8 years with a sample standard deviation of 6.6 years
and a range of three months to 34 years. 50% of participants had had mycetoma for 0–5 years,
23% for 5–10 years, and 27% for more than 10 years. Most individuals (270, 90%) reported a
mycetoma lesion in the lower limb (hip through to toes), 23 patients (8%) had a mycetoma
lesion in the upper limb, six patients (2%) reported the lesion in the head and neck, and one
participant reported mycetoma in multiple sites. Most patients (203, 68%) had had local surgi-
cal excision (most frequently at rural hospital sites), of these 140 (69%) had had recurrence.
Seven patients had undergone amputation, of whom two had had recurrence.
Ethics statement
Ethical clearance was obtained from the Mycetoma Research Centre IRB and every patient
gave verbal informed consent. Written consent was decided to be not necessary as the patients’
identity was not disclosed in this article. The patients’ verbal informed consent acceptance was
documented in each questionnaire during the interview.
Cumulative disability scores
The study showed that 49 (16.3%) of all participants had no difficulty or impairment in any of
the 33 studied variables (Table 2). These patients were slightly younger, with a mean age of 29
years and an age range of 7 to 65; and they had had mycetoma for a shorter duration than the
average (mean 6.9 years, range 0.5–20 years). Their most common occupations were students
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(22%) or housewives (16%). All other patients (251, 83.7%) experienced disability ranging
from mild to severe. The mean cumulative disability score for all degrees of disability among
the studied patients was 10.7 with a range of 0 to 68. Most of the patients (133, 44.3%) had a
score between 1 and 10. 62 patients (20.7%) had a score of 10–20, 31 patients (10.3%) had a
score of 20–30, and 25 patients (8.3%) had a score of more than 30. The study showed that 181
patients (60.3%) had moderate impairment or difficulty in at least one domain variable. The
scores were highest among farmers, those not in income-generating work, elderly patients and
those with a longer disease duration.
Results by variable
In this study, 103 patients (34.3%) had local pain of various degrees at the mycetoma site
(Table 3). Mild pain was confirmed by 70 patients (23.3%), 23 patients (8%) had moderate
pain, and 10 (3%) had severe pain. Worsening of pain was statistically significantly correlated
with advanced age; (p<0.01). No results are available for analgesic control in this population
(Fig 1).
In this study, 119 patients (39.7%) reported walking difficulty, (Table 4): 54 patients (18%)
had mild difficulty, 36 patients (12%) had moderate difficulty, 23 patients (8%) had severe dif-
ficulty, and six patients (2%) were completely unable to walk. Worsening of walking ability
was statistically significantly associated with advanced age (p<0.01), longer disease duration
(p<0.01), and pain at the lesion site (p<0.01).
In self-care, the activities that predominantly require upper limb mobility are least affected
by mycetoma and score lowest (eating, drinking, etc.; Table 5). Impaired ability to self-dress
was reported by 112 patients (38%): mild impairment in 86 patients (29%), moderate in 22
patients (7%), severe in three patients (1%) and complete in one patient (0.3%). Impairment
inability to dress oneself was statistically significantly correlated to the presence of pain at the
mycetoma site (p<0.01); but not with advanced patient age or longer duration of the myce-
toma. Proportionally, most impairment in self-care is marked as mild (dressing 76.8%, wash-
ing 71.2%, toileting 74.6%; Fig 2).
Table 2. Overall assessment of mycetoma disability using cumulative disability scoring.
Disability Scoring No. %
All patients No difficulty/Impairment 49 16.3
Score of 1–10 133 44.3
Score of 10–20 62 20.7
Score of 20–30 31 10.3
Above 30 25 8.3
Total 300 100.0
https://doi.org/10.1371/journal.pntd.0007019.t002
Table 3. Impairments in body function.
Degree of Impairment Energy and Drive Sleep Emotional Body Image Pain Sensation Weight Maintenance
None 220 269 224 216 197 236
Mild 52 18 47 37 70 46
Moderate 26 11 28 42 23 17
Severe 01 02 01 03 10 01
Complete 00 00 00 00 00 00
Missing records 01 00 00 02 00 00
Total no. with some impairment 79 31 76 82 103 64
% with impairment 26.4 10.3 25.3 27.5 34.3 21.3
https://doi.org/10.1371/journal.pntd.0007019.t003
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The study showed that 164 patients (55%) had difficulty in going about their daily life,
(Table 6). A mild difficulty was reported by 63 patients (23%), 28 (9%) had moderate difficulty,
22 (7%) had severe difficulty, and 51 (17%) were completely unable to go about at least one
aspect of their daily life because of the mycetoma. Many patients marked these sections as not
applicable to them which was largely to do with male/female gender roles in domestic life.
Generally speaking, in Sudan males are less likely to be involved in domestic life activities than
females.
Fig 1. A lady with mycetoma supported by two family members to execute her normal live activities.
https://doi.org/10.1371/journal.pntd.0007019.g001
Table 4. Difficulties in mobility.
Capacity Hand & Arm Use Walking Transportation Driving
No difficulty 273 181 214 93
Mild Difficulty 19 54 47 09
Moderate Difficulty 05 36 19 01
Severe Difficulty 01 23 09 04
Complete Inability 01 06 04 14
Missing records 01 00 00 00
Not applicable 00 00 07 179
Total no. With difficulty 26 119 79 28
% with impairment 8.7 40.0 26.3 23.1
https://doi.org/10.1371/journal.pntd.0007019.t004
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Table 5. Difficulties in self care.
Capacity Washing Toileting Dressing Eating Drinking
No difficulty 225 242 187 291 292
Mild Difficulty 52 41 86 06 04
Moderate Difficulty 16 8 22 02 00
Severe Difficulty 02 02 03 00 00
Complete Inability 03 04 01 00 00
Missing 00 02 00 00 01
Not applicable 02 01 01 01 03
Total no. with difficulty 73 55 112 08 04
% with impairment 25.5 18.5 40.8 2.7 1.4
https://doi.org/10.1371/journal.pntd.0007019.t005
Fig 2. A patient carried consistently by his brother due to disability.
https://doi.org/10.1371/journal.pntd.0007019.g002
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Regarding interpersonal relationships, 57 (19%) patients reported difficulty, (Table 7). Mild
difficulty was reported by 33 patients (11%), 15 patients (5%) reported moderate difficulty, six
patients (2%) reported severe difficulty and three patients (1%) reported a complete inability
to relate in the area of interpersonal interaction.
Of the 300 interviewed patients, 37 were of school age (Table 8). Of these, 21 reported
no difficulty at attending school while 16 reported present or previous difficulty. Twelve
patients reported that mycetoma rendered them completely unable to continue their school
education. Eighteen patients had the potential to gain higher education of whom seven experi-
enced difficulty due to their mycetoma: four experienced mild difficulty, one experienced
moderate difficulty, one experienced severe difficulty, and one was completely unable to con-
tinue their higher education because of their mycetoma. While the survey format did not allow
us to collect information from all who reported that mycetoma had made continuing in school
difficult or impossible, anecdotal comments to the data collectors identified mobility impair-
ments that made walking to school difficult or impossible as the key barrier to continuing
school attendance.
Using the ICF definition of ‘economic status’ as “having economic resources from any
source enough to ensure economic security in the present and the future” in the study, 126
patients (46.7%) reported a reduction in their ability to economically sustain themselves
because of their mycetoma (Table 9). Mild difficulty was reported by 47 patients (17%) in their
ability to be economically self-sufficient because of their mycetoma, 36 patients (13%) reported
moderate difficulty, 19 patients (7%) reported severe difficulty, and 24 patients (9%) were
completely economically non-self-sufficient because of their mycetoma.
Specifically, 69 patients (40%) out of a relevant 173 patients found difficulty in their remu-
nerative employment: 24 patients (14%) experienced mild difficulty, 10 patients (6%)
Table 6. Difficulties in domestic life activities.
Capacity Shopping Gathering Daily Necessities Preparing Meals Doing Housework
No difficulty 175 132 87 119
Mild Difficulty 23 12 10 18
Moderate Difficulty 07 05 04 12
Severe Difficulty 04 09 05 04
Complete Inability 15 20 07 09
Missing 00 01 01 01
Not applicable 76 121 186 137
Total no. with difficulty 49 46 26 43
% with impairment 21.9 25.8 23.0 26.5
https://doi.org/10.1371/journal.pntd.0007019.t006
Table 7. Difficulties in interpersonal interactions and relationships.
Capacity Informal Social Relationships Family Relationships Intimate Relationships
No difficulty 267 283 140
Mild Difficulty 15 13 5
Moderate Difficulty 10 2 3
Severe Difficulty 4 1 1
Complete Inability 3 0 0
Missing record 0 0 0
Not applicable 1 1 151
Total no. with some difficulty 32 16 9
% with impairment 10.7 5.4 6.0
https://doi.org/10.1371/journal.pntd.0007019.t007
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moderate, six patients (4%) severe and 29 patients (17%) were completely unable to work for
remunerative gain because of their mycetoma. There were 127 non-applicable individuals,
who were not in work previously.
Impairment in remunerative employment was significantly correlated with the presence of
pain (p<0.05), impairment in walking (p<0.01) and impairment in economic self-sufficiency
(p<0.01). Impairment in economic self-sufficiency was also significantly correlated with the
presence of pain (p<0.01) and impairment in walking (p<0.01) but also advanced age
(p<0.01). Neither was correlated with duration of the mycetoma.
Of the 296 patients who reported that participation in a range of community activities were
important to them, 63 (21.3%) experienced difficulty in participation because of the myce-
toma, with 20 patients (7%) reporting mild, 22 patients (8%) moderate, and six patients (2%)
severe limitations (Table 10). An additional 15 patients (5%) reported that they were
completely unable to participate in community events or ceremonies. Of the 216 patients to
whom recreation or leisure was important, 21 patients (9.7%) experienced difficulty in partici-
pation. Of the 107 patients to whom sports were relevant, 68 patients (63.6%) experienced dif-
ficulty, of whom four patients (4%) experienced mild difficulty, six patients (6%) moderate
difficulty, seven patients (7%) severe, and 51 (48%) reported being completely unable to partic-
ipate in sports because of their mycetoma. Of this study population, 54 patients out of 290
(19%) experienced difficulty in socialising, whilst 71 patients out of 295 (24.1%) experienced
difficulty in participating in religious activities (Fig 3).
Discussion
There is a general paucity of literature investigating the nexus of neglected tropical diseases
and disability, though existing work supports our main findings. A study addressing leprosy-
Table 8. Difficulties in attending education.
Capacity School Education Higher Education
No difficulty 21 11
Mild Difficulty 01 04
Moderate Difficulty 02 01
Severe Difficulty 01 01
Complete Inability 12 01
Missing 00 00
Not applicable 263 282
Total no. with some difficulty 16 07
% with impairment 44.4 38.9
https://doi.org/10.1371/journal.pntd.0007019.t008
Table 9. Difficulties in economic status.
Capacity Remunerative Employment Economic Self Sufficiency
No difficulty 104 143
Mild Difficulty 24 47
Moderate Difficulty 10 36
Severe Difficulty 06 19
Complete Inability 29 24
Missing 00 01
Not applicable 127 30
Total no. with some difficulty 69 126
No. with impairment % 39.9 46.7
https://doi.org/10.1371/journal.pntd.0007019.t009
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related disability highlights the disease’s economic impact and association with extreme pov-
erty. It also shows that people with a leprosy-related disability achieved fewer individual and
family related objectives without interventions recognising their disability [32]. Work in
malaria and tuberculosis also shows the importance of qualitative approaches in elucidating
the nature of the disease-related disability, its interaction with poverty and related barriers to
care [33, 34].
Our study is the first which measures and characterises mycetoma-related disability. It also
clearly links mycetoma-related disability with a negative impact on economic livelihood. Over-
all, 83.7% of the studied patients report disability in one or more of the 33 ICF domains exam-
ined, with 60.3% reporting at least moderate disability in one or more domain. Further
analysis reveals areas of differential impact along the lines of gender and age, alongside specific
vulnerabilities common to all those with mycetoma, including pain, impaired mobility and
stigma.
Four times as many males are diagnosed with this disease as females, suggesting variations
either in incidence patterns or in societal responses, and hinting at gender-based vulnerabili-
ties requiring further research. There may be true gender variation in disease incidence, relat-
ing to increased likelihood of traumatic injury allowing pathogenic inoculation, or to a
hormonal influence on disease progression in males [35]. An alternative explanation is that
women may be less likely to seek or receive medical care due to stigma, financial or ‘gender-
role’ considerations, leading to reporting bias. This alternative is supported by a village level
survey which showed that gender and age distributions were more evenly distributed than
those measured at the tertiary level [15]. Indeed in endemic areas, females may in fact have
similar risks of exposure as men, due to extensive outdoor activities. Either explanation hints
at a particular vulnerability rooted in gender.
There are two striking age-related impacts. Firstly, older adults bear a greater burden of dis-
ability overall than younger patients or students, suggesting that symptoms may correlate with
both disease duration, and therefore disease progression, and with physical activity and pain.
Secondly, there is a strong effect on educational attendance in the school-age population
where 44.4% of students with mycetoma experience difficulty in attending primary school,
and 38.9% struggle to attend higher education. Our study did not formally assess this effect
further, but physical inability to walk to school was mentioned by several interviewees as an
underlying cause. For school-age children with little or no access to transport to school facili-
ties, this would represent a strong barrier to accessing education. Illness and disease have also
been shown to negatively impact a child’s learning and school time in less developed settings
[36]. The combined effects of decreased access and poorer quality of learning when in lessons
are likely to result in unfulfilled potential and loss of future opportunities.
Table 10. Impairments in community, social and civic life.
Capacity Ceremonies Recreation & Leisure Sports Socialising Religion
No difficulty 233 195 39 236 224
Mild Difficulty 20 09 04 26 39
Moderate Difficulty 22 03 06 10 24
Severe Difficulty 06 02 07 8 3
Complete Inability 15 07 51 10 05
Missing 00 0 0 0 00
Not applicable 04 84 193 10 05
Total no. with some difficulty 63 21 68 54 71
No. with impairment % 21.3 9.7 63.6 18.6 24.1
https://doi.org/10.1371/journal.pntd.0007019.t010
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Three further mycetoma-related effects are worth discussing for their creation of particular
vulnerabilities common to all individuals with the disease. These include pain, limited mobility
and stigma. Mycetoma is typically characterised as a painless disease, although there are
reports of local pain at the mycetoma site and that is frequently due to secondary bacterial
infection [37, 38, 39]. However, in this study over a third of respondents (103 patients, 34.3%)
reported local pain, higher than has been previously reported [2, 4, 20]. Whilst most cases were
mild, infrequent and tolerable, this challenges the idea that mycetoma is generally painless. It
is likely to result in vulnerabilities correlating with poorer development and achievement out-
comes including school attendance, academic performance and the ability to perform physical
tasks, both domestic and professional.
Fig 3. A lady supported by her sister to attend social event.
https://doi.org/10.1371/journal.pntd.0007019.g003
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Walking itself receives high impact scores with 119 patients (40.0%) complaining of restric-
tion in their ability to walk without assistance. The assessment questions point towards
impairment being produced by the mycetoma itself, rather than other co-morbidities or age-
associated frailties. In general, co-morbidities are rare in mycetoma as most of the patients by
number are young adults and children (though notably those with the most disabling conse-
quences are the elder patients). The associations between a sedentary lifestyle and non-com-
municable diseases are well-known however and those with mycetoma-related physical
restriction are likely to be at increased risk for them.
A substantial number of respondents reported reduced participation in education, commu-
nity, religious, social and civic life. This could be partly a result of stigma and social isolation,
either because of specific beliefs about the disease e.g. contagion, linkage of physical and spiri-
tual malady, or due to broader prejudice against individuals with a disability.
However, less than 20% of respondents reported difficulties in socialising (18.6%), with just
7% reporting difficulties in interpersonal relationships overall. Furthermore, relatively few
patients had impairments in such bodily functions as energy and drive (26%), emotional func-
tion (25%) or body image impairment (27.5%). These findings might be explained by the local-
ised, slowly progressive nature of the disease, together with the rarity of cosmetically
‘significant’ areas, such as the face, being affected.
It is also interesting to note that few patients had impairment in informal social- (11%),
family- (5%) or intimate- (6%) relationships. This may be a finding particular to the study set-
ting, partly related to the strong concept of the extended families in the Sudan, where patients
receive support and care from many family members even if they are not close relatives.
Overall these findings suggest that in the context of Sudan reduced participation in aspects
of public life may be influenced as much by physical issues as by social stigma. Further work is
needed to explore this complex area.
The most common limitation, by a number of people affected, was in economic self-suffi-
ciency (126 affected, 46.8% of applicable patients). Self-sufficiency here was defined as having
enough economic resources from any source to ensure economic security in the present and
the future [30]. A component of this is likely to be disease-related inability to work. Indeed
40% of those who would otherwise be in work were partially or completely unable to engage in
remunerative employment because of their mycetoma. Our results do not explore the exact
nature of this loss in economic self-sufficiency, however we know that even where treatment is
available free of charge, such as that provided at the MRC, indirect healthcare costs (e.g. cost of
transport, loss of paid work) are consistently a significant burden on household economies
[40]. An emerging body of research evidence also shows that individuals living with a disabil-
ity, and households with disabled members, face increased costs compared to those without,
e.g. for medical care, transportation, loss of paid work both by the affected individual and by
those who remain at home to provide care [41,42].
In this study, there were four main limitations. Firstly, data collection was based on the ICF
Model, rather than the Washington Group (WG) Questions on Disability Statistics [43]. This
was because the project was initiated and data was collected prior to awareness of the WG
methodology by field research staff. There is some overlap, since the WG questions are based
upon the ICF Model, however the WG methodology captures dimensions of individual func-
tioning more precisely and should be the basis of future work. Nevertheless, we believe our
data remains valid, relevant and yields new insight into mycetoma-related disability. Secondly,
data collectors were recent medical graduates without backgrounds in research or disability.
Therefore extensive training and support was given to minimise the risk of decreased accuracy
or reliability of results. Third, our data is predominantly quantitative, save for anecdotes
reported to data collectors. A qualitative component in further research could add further
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valuable insight into how individuals and societies are affected. And finally, although this was
not the purpose of the study, we did not record whether patients had actinomycetoma or
eumycetoma and are unable to perform a subgroup analysis of these groups to look for differ-
ences in disability.
In conclusion, this is the first study to outline the burden of disability caused by mycetoma.
It shows clear evidence of mycetoma-related impact on individuals’ body function, mobility,
and ability to self-care, with significant ramifications for domestic life, interpersonal relation-
ships, educational attainment, economic status, and civic engagement. There is sufficient evi-
dence to support specific interventions aiming to mitigate and adapt to the disabling
consequences of mycetoma. However, better detection and disease education are also impor-
tant for preventing infection and the development of mycetoma-related disability.
Clinically, effective pain management should be routinely integrated into mycetoma ser-
vices, particularly for those groups identified as higher risk such as farmers and older adults.
Different analgesic agents can be evaluated for efficacy against mycetoma-related pain. More
definitive treatment should include the elimination of the secondary bacterial infection by
appropriate anti-pathogenic agents and repeated lesion debridement. Further addition of
physiotherapy services could begin to address limitations of mobility and function. Simple
walking aids could be a starting point followed by in-house physiotherapy services. They could
also provide a starting point for reducing risks associated with sedentary lifestyles.
In education, services could include assessment of a student’s mycetoma-related disability
using a pragmatic screening tool based on our results. This would inform adaptations in edu-
cational provision, including greater local awareness and consideration of learning aids or
adaptations that allow distance learning, participation in physical and sporting activities, in
modifying transport to and from school as well as mitigating stigma in educational settings.
This study shows evidence of impaired revenue generation at an individual level and a neg-
ative impact on economic self-sufficiency and household income. While this establishes that
diseases such as mycetoma have significant development and public health implications, fur-
ther research is needed to quantify its financial effects at the individual, household and societal
levels. This includes effects on revenue generation, career opportunities and health-related
costs, including the reallocation of disposable assets.
Above all, our data emphasise that the multi-faceted, long-term disabling consequences of
NTDs, such as mycetoma, must not be overlooked. Their effects are likely to be felt at the level
of individuals, families and communities, across multiple social and economic dimensions.
Importantly, such effects are likely to be modifiable and therefore must be considered and
addressed in future policy and programming.
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